Sign inJoin waitlistJoin the waitlist

Terry Jones

Dermatology · Epiphany Dermatology Pa

Credentials: · ·

History

Epiphany Dermatology of New Jersey LLC
Chief Resident
1975–1978
Preliminary or Transitional Year
1974–1975
Baylor College of Medicine
1970–1974
Austin College (Sherman, TX) – BA, Biology
1966–1970

Research

OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
Proceedings of the National Academy of Sciences of the United States of America · 2018 · 521 citations
Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial
Obstetrics and Gynecology · 1997 · 168 citations
Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study
Journal of the American Academy of Dermatology · 2007 · 129 citations

ET
Eduardo Tschen
10 papers
MJ
Michael Jarratt
8 papers
Anne Lucky
5 papers
DP
David Pariser
5 papers
SK
Steven Kempers
5 papers
James Leyden
4 papers
NL
Nicholas Lowe
4 papers
PR
Phoebe Rich
4 papers
DC
Dan Chalker
3 papers
ER
Elyse Rafal
3 papers
JS
John Strauss
3 papers
Adelaide Hebert
2 papers

Clinical trials

To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis
Principal investigator · Unknown · Phase 2
Hallux, Inc.
2022–2024
Phase 1 Safety and PK Study of OLT1177 Capsules
Principal investigator · Completed · Phase 1
Olatec Therapeutics, Inc.
2014
Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects
Principal investigator · Completed · Phase 1
Olatec Therapeutics, Inc.
2012
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Principal investigator · Completed · Phase 3
Galderma R&D
2011–2012